Drug Name |
Lacosamide
|
||
Synonyms |
Erlosamide; Harkoseride; Vimpat; Erlosamide [INN]; Lacosamide [USAN]; ADD 234037; SPM 927; ADD-234037; SPM-927; SPM-929; Erlosamide, Vimpat, Lacosamide; Lacosamide (USAN/INN); (2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide; (2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide; (2R)-2-acetamido-N-benzyl-3-methoxypropanamide
|
||
Drug Type |
Small molecular drug
|
||
Indications |
Convulsion [ICD-11: 8A68.Z]
|
Approved
|
|
Epilepsy [ICD-11: 8A60-8A68]
|
Approved
|
||
Diabetic neuropathy [ICD-11: 8C0Z]
|
Phase 3
|
||
Company |
Schwarz Pharma
|
||
Summary |
Lacosamide is an antiepileptic drug used to treat partial onset seizures in adults.
|
||
Target |
Dihydropyrimidinase related protein 2 (DPYSL2)
Mechanism of Action: Modulator
|
T92078 | |
Voltage-gated sodium channel alpha Nav1.9 (SCN11A)
Mechanism of Action: Inhibitor
|
T34123 | ||
Voltage-gated sodium channel (Nav)
Mechanism of Action: Inhibitor
|
T72065 |
![]() |
Formula |
C13H18N2O3
|
Canonical SMILES |
CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1
|
|
InChI |
1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1
|
|
InChIKey |
VPPJLAIAVCUEMN-GFCCVEGCSA-N
|
|
CAS Number | CAS 175481-36-4 | |
TTD ID | D05OFX | |
DrugBank ID | DB06218 | |
PubChem Compound ID | 219078 | |
PubChem Substance ID |
9374274
,
12015335
,
14847708
,
15196715
,
30422445
,
50069298
,
51091636
,
53505872
,
57399840
,
58107206
,
99218530
,
99298399
,
99437053
,
103245465
,
104154565
,
109693474
,
113468551
,
123121578
,
124757118
,
125163922
,
126575044
,
126624062
,
126644682
,
126667072
,
126733504
,
129508865
,
134339319
,
135141960
,
135367753
,
135697647
,
135707761
,
136895303
,
136991060
,
137237313
,
137237672
,
139113413
,
152258417
,
160647253
,
160660621
,
160826045
,
162037520
,
162188094
,
163092695
,
163589394
,
164824528
,
170466190
,
172086321
,
174006177
,
174527897
,
175266112
|
|
ChEBI ID | CHEBI:135939 | |
ADReCS Drug ID | BADD_D01238 |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |